日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeted insertion of heterogenous DNA using Cas9-gRNA ribonucleoprotein-mediated gene editing in Ganoderma lucidum

利用Cas9-gRNA核糖核蛋白介导的基因编辑技术在灵芝中靶向插入异质DNA

Eom, Hyerang; Choi, Yeon-Jae; Nandre, Rutuja; Kim, Minseek; Oh, Youn-Lee; Kim, Sinil; Nakazawa, Takehito; Honda, Yoichi; Ro, Hyeon-Su

An overview of immunotoxicity in drug discovery and development

药物发现和开发中的免疫毒性概述

Nandre, Rahul M; Terse, Pramod S

Nonclinical Safety Evaluation of 2-Deoxy-D-Glucose Following Twice-Daily Oral Administration for 28 Days in Beagle Dogs

比格犬每日两次口服2-脱氧-D-葡萄糖28天的非临床安全性评价

Nandre, Rahul M; Joshi, Pramod S; Sutula, Thomas P; Terse, Pramod S

In vitro safety evaluation of dopamine D3R antagonist, R-VK4-116, as a potential medication for the treatment of opioid use disorder

多巴胺 D3R 拮抗剂 R-VK4-116 作为治疗阿片类药物使用障碍的潜在药物的体外安全性评估

Rahul M Nandre, Amy Hauck Newman, Pramod S Terse

The Cas9-gRNA ribonucleoprotein complex-mediated editing of pyrG in Ganoderma lucidum and unexpected insertion of contaminated DNA fragments

Cas9-gRNA核糖核蛋白复合物介导的灵芝pyrG编辑和污染DNA片段的意外插入

Hyerang Eom, Yeon-Jae Choi, Rutuja Nandre, Hui-Gang Han, Sinil Kim, Minseek Kim, Youn-Lee Oh, Takehito Nakazawa, Yoichi Honda, Hyeon-Su Ro

IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status

IDO疫苗可清除免疫抑制性髓系细胞群,并增强抗肿瘤作用,且该作用独立于肿瘤细胞IDO状态。

Rahul Nandre # ,Vivek Verma # ,Pankaj Gaur ,Veerupaxagouda Patil ,Xingdong Yang ,Zainab Ramlaoui ,Nour Shobaki ,Mads Hald Andersen ,Ayako Wakatsuki Pedersen ,Mai-Britt Zocca ,Mikayel Mkrtichyan ,Seema Gupta ,Samir N Khleif

Comparative structural analysis on the mitochondrial DNAs from various strains of Lentinula edodes

对不同香菇菌株线粒体DNA的比较结构分析

Kim, Sinil; Eom, Hyerang; Nandre, Rutuja; Choi, Yeon Jae; Lee, Hwayong; Ryu, Hojin; Ro, Hyeon-Su

Outcomes of COVID-19 in Pregnant Women with Sickle Cell Disease in India: A Case Series

印度镰状细胞病孕妇感染 COVID-19 的结局:病例系列研究

Waghmare, Rakesh; Chaaithanya, Itta Krishna; Zala, Sarika; Deshmukh, Jitendra; Uikey, Prashant; Wankhede, Sarika; Palve, Tushar; Sirsam, Shyamkumar; Chavan, Rohidas; Waikar, Manjushri; Humane, Anil; Khobragade, Akash; Akare, Monika; Sondawale, Ritesh K; Sharma, Rajat; Nandre, Vrushali; Howal, Prashant; Modi, Deepak N; Mahale, Smita D; Gajbhiye, Rahul K

MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects

MEK抑制剂可将CD8+ T淋巴细胞重编程为具有强大抗肿瘤作用的记忆干细胞。

Vivek Verma ,Nazli Jafarzadeh ,Shannon Boi ,Subhadip Kundu ,Zhinuo Jiang ,Yiping Fan ,Jose Lopez ,Rahul Nandre ,Peng Zeng ,Fatmah Alolaqi ,Shamim Ahmad ,Pankaj Gaur ,Simon T Barry ,Viia E Valge-Archer ,Paul D Smith ,Jacques Banchereau ,Mikayel Mkrtichyan ,Benjamin Youngblood ,Paulo C Rodriguez ,Seema Gupta ,Samir N Khleif

PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance

在亚激活的CD8细胞中阻断PD-1会诱导功能异常的PD-1+CD38hi细胞和抗PD-1耐药性。

Vivek Verma ,Rajeev K Shrimali ,Shamim Ahmad ,Winjie Dai ,Hua Wang ,Sumin Lu ,Rahul Nandre ,Pankaj Gaur ,Jose Lopez ,Moshe Sade-Feldman ,Keren Yizhak ,Stacey L Bjorgaard ,Keith T Flaherty ,Jennifer A Wargo ,Genevieve M Boland ,Ryan J Sullivan ,Gad Getz ,Scott A Hammond ,Ming Tan ,Jingjing Qi ,Phillip Wong ,Taha Merghoub ,Jedd Wolchok ,Nir Hacohen ,John E Janik ,Mikayel Mkrtichyan ,Seema Gupta ,Samir N Khleif